China’s Genuine Biotech nets $100m co-led by Efund Capital, and Yingke PE

China’s Genuine Biotech nets $100m co-led by Efund Capital, and Yingke PE

Photo: Pixabay

27 August, 2021

ABC Capital China Fortune Financial Group Efund Capital Genuine Biotech Yingke PE

Printed by Unregistered user on Mon, 08 Dec 2025 15:16:05 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China-US drugmaker JOINN Biologics raises $150m in Series B led by CPE

China’s Health Guard raises $157m in pre-IPO round from CCBI, Yunfeng Capital, others

Read more from Greater China

IDG, others pour over $141m into Chinese new materials maker Xingi

Venture Capital

China’s Fudan University sets up $100m fund for early-stage startups